Use of anti‐hypertensive medication was common in both groups, with more CON participants taking angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEi/ARB) versus the CKD group (p = 0.01). Here, ACE is linked to chronic kidney disease.